Applicaiton Required
ISPY1
Payment instrument
Free
Update frequency
Irregular
ACRIN 6657 was designed as a prospective study to test MRI for ability to predict response to treatment and risk-of-recurrence in patients with stage 2 or 3 breast cancer...